Cargando…
A suggested follow-up time for breast cancer patients.
The data for this study, consisting of 300 females treated for breast cancer in 1951-1961, were evaluated in order to ascertain when excess mortality from breast cancer disappears and what would be an appropriate follow-up period for investigational purposes. The clinical stages of the patients were...
Autores principales: | Leivonen, M. K., Saario, I. A., Peltokallio, P., Tuominen, L., Kalima, T. V. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001540/ https://www.ncbi.nlm.nih.gov/pubmed/3801277 |
Ejemplares similares
-
Malignant tumours of the male breast in Finland. A report of 51 cases.
por: Peltokallio, P., et al.
Publicado: (1969) -
Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.
por: Railo, M., et al.
Publicado: (1993) -
Urinary epidermal growth factor concentrations in various human malignancies.
por: Mattila, A. L., et al.
Publicado: (1988) -
Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case for
por: Dixon, J Michael, et al.
Publicado: (2008) -
The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors
por: Savinainen, J R, et al.
Publicado: (2012)